3rd Annual MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference ( Time Zone

MarketsandMarkets is proud to announce the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 22nd -23rd, 2020.

While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.

Our aim for the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference is to unite all stakeholders in a virtual room during these remarkable times to see how to use conventional informational indexes and layer that in with innovative analytical techniques and new working models.

The virtual conference will also hold discussion on the impact due to COVID-19 in RWD space- Identifying and overcoming those challenges efficiently

Key Highlights

Progression on uses of Real-World Data across the ecosystem
Global regulatory perspective on Real-World Evidence Guidance- FDA & EMA
Applications of Artificial Intelligence & Blockchain for Real-World Data Analysis
Market Access and Pricing
COVID-19 impact- Identifying and overcoming challenges in Real-World Evidence space

Who Should Attend?

From pharmaceutical and Biopharmaceutical companies-

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists, Bio-Statisticians, Epidemiologist, within the following departments

Real-World Evidence
Health Economics & Outcomes Research
Patient Access
Value Access
Clinical Operations
Clinical Development
Center for Observational and Real-World Evidence

Why Attend?

Understand the impact of innovative real-world evidence partnerships for better data
To explore the capabilities of using Artificial Intelligence & Machine Learning for better Data Analysis
Learn about global regulatory perspective on Real-World Evidence Guidance
Learn about best practices for the commercial structure of drugs, from development to market access strategy
Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution providers